{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-073776","form_type":"8-K","ticker":"NNDM","cik":"0001643303","company_name":"Nano Dimension Ltd.","filed_at":"2026-06-15T11:48:12+00:00","discovered_at":"2026-06-15T11:50:00.463487+00:00","generated_at":"2026-06-15T11:50:14.023063+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nano Dimension signs non-binding term sheet to acquire Infinite Epigenetics for $890M stock consideration","bullets":["Infinite valued at $890M; Nano valuation based on net cash plus 20% premium plus ~$20M for Essemtec.","Post-closing, Infinite shareholders to own majority; if >55%, they designate 5 of 7 board seats.","Nano will spin off legacy assets via CVR to pre-closing Nano shareholders.","Term sheet includes 30-day exclusivity; no definitive agreement yet.","Nano to reimburse Infinite up to $3M expenses if definitive deal not signed by EGM date."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-073776","json":"https://secwatch.observer/filing/0001104659-26-073776.json","markdown":"https://secwatch.observer/filing/0001104659-26-073776.md","text":"https://secwatch.observer/filing/0001104659-26-073776.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1643303/000110465926073776/0001104659-26-073776-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1643303/000110465926073776/tm2617934d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T11:50:14.023063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}